Combination of BRAF and VEGF Inhibitors
    43.
    发明申请
    Combination of BRAF and VEGF Inhibitors 审中-公开
    BRAF和VEGF抑制剂的组合

    公开(公告)号:US20130172378A1

    公开(公告)日:2013-07-04

    申请号:US13820834

    申请日:2011-09-02

    Applicant: Rakesh Kumar

    Inventor: Rakesh Kumar

    Abstract: A novel combination comprising the VEGFR inhibitor 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, or a pharmaceutically acceptable salt thereof, with a B-Raf inhibitor, particularly N-(3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl)-2,6-difluorobenzenesulfonamide or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of VEGFR and/or B-Raf is beneficial.

    Abstract translation: 包含VEGFR抑制剂5 - [[4 - [(2,3-二甲基-2H-吲唑-6-基)甲基氨基] -2-嘧啶基]氨基] -2-甲基苯磺酰胺或其药学上可接受的盐的新型组合, 与B-Raf抑制剂,特别是N-(3- [5-(2-氨基-4-嘧啶基)-2-(1,1-二甲基乙基)-1,3-噻唑-4-基] -2-氟苯基 )-2,6-二氟苯磺酰胺或其药学上可接受的盐,包含其的药物组合物以及在治疗VEGFR和/或B-Raf的抑制有益的条件下使用这些组合和组合物的方法。

    RULE-BASED DETERMINATION AND VALIDATION IN BUSINESS OBJECT PROCESSING
    44.
    发明申请
    RULE-BASED DETERMINATION AND VALIDATION IN BUSINESS OBJECT PROCESSING 有权
    基于规则的业务对象处理确定和验证

    公开(公告)号:US20130166472A1

    公开(公告)日:2013-06-27

    申请号:US13335430

    申请日:2011-12-22

    CPC classification number: G06Q10/10 G06Q10/06 H04L67/02

    Abstract: A method to model a business object is disclosed. An analysis module analyzes elements of a business object. A modeling module models business object logic based on the elements of the business object. An implementation module implements the modeled business object logic. A repository stores the modeled business object logic. A business object runtime module executes the modeled business object logic.

    Abstract translation: 公开了一种用于建模业务对象的方法。 分析模块分析业务对象的元素。 建模模块基于业务对象的元素来模拟业务对象逻辑。 实现模块实现建模的业务对象逻辑。 存储库存储建模的业务对象逻辑。 业务对象运行时模块执行建模的业务对象逻辑。

    COMBINATION
    45.
    发明申请
    COMBINATION 有权
    组合

    公开(公告)号:US20130109705A1

    公开(公告)日:2013-05-02

    申请号:US13699077

    申请日:2011-05-19

    Abstract: The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine, or a pharmaceutically acceptable hydrate and/or salt thereof, and N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethy;-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, to a human in need thereof.

    Abstract translation: 本发明涉及一种治疗人类癌症的方法和用于治疗的药物组合物。 特别地,该方法涉及一种癌症治疗方法,其包括给予N- {3-氯-4 - [(3-氟苄基)氧基]苯基} -6- [5 - ({[2-(甲磺酰基)乙基]氨基 }甲基)-2-呋喃基] -4-喹唑啉胺或其药学上可接受的水合物和/或盐和N- {3- [3-环丙基-5-(2-氟-4-碘 - 苯基氨基) -2,4,7-三氧代-3,4,6,7-四氢-2H-吡啶并[4,3-d]嘧啶-1-基]苯基}乙酰胺或其药学上可接受的盐或溶剂化物 对有需要的人。

    COMBINATION
    46.
    发明申请
    COMBINATION 审中-公开
    组合

    公开(公告)号:US20120322817A1

    公开(公告)日:2012-12-20

    申请号:US13497576

    申请日:2010-09-23

    Abstract: The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, and N-{(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof.

    Abstract translation: 本发明涉及一种治疗人类癌症的方法和用于治疗的药物组合物。 特别地,该方法涉及一种癌症治疗方法,其包括给予N- {3- [3-环丙基-5-(2-氟-4-碘 - 苯基氨基)-6,8-二甲基-2,4,7- 三氧代-3,4,6,7-四氢-2H-吡啶并[4,3-d]嘧啶-1-基]苯基}乙酰胺或其药学上可接受的盐或溶剂化物,和N - {(1S)-2 - 氨基-1 - [(3,4-二氟苯基)甲基]乙基} -5-氯-4-(4-氯-1-甲基-1H-吡唑-5-基)-2-呋喃甲酰胺或其药学上可接受的 其盐,需要其的人。

    COMBINATION
    47.
    发明申请
    COMBINATION 审中-公开
    组合

    公开(公告)号:US20120283278A1

    公开(公告)日:2012-11-08

    申请号:US13497580

    申请日:2010-09-23

    Abstract: The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, and N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof.

    Abstract translation: 本发明涉及一种治疗人类癌症的方法和用于治疗的药物组合物。 特别地,该方法涉及一种癌症治疗方法,其包括给予N- {3- [3-环丙基-5-(2-氟-4-碘 - 苯基氨基)-6,8-二甲基-2,4,7- 三氧代-3,4,6,7-四氢-2H-吡啶并[4,3-d]嘧啶-1-基]苯基}乙酰胺或其药学上可接受的盐或溶剂化物,和N - {(1S)-2 - 氨基-1 - [(3-氟苯基)甲基]乙基} -5-氯-4-(4-氯-1-甲基-1H-吡唑-5-基)-2-噻吩甲酰胺或其药学上可接受的盐 ,对有需要的人。

    COMBINATION
    49.
    发明申请
    COMBINATION 有权
    组合

    公开(公告)号:US20120196886A1

    公开(公告)日:2012-08-02

    申请号:US13500241

    申请日:2010-10-08

    CPC classification number: A61K31/506 A61K31/4155 A61K45/06 A61K2300/00

    Abstract: The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide or a pharmaceutically acceptable salt thereof, and N-{(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof.

    Abstract translation: 本发明涉及一种治疗人类癌症的方法和用于治疗的药物组合物。 特别地,该方法涉及一种癌症治疗方法,其包括给予N- {3- [5-(2-氨基-4-嘧啶基)-2-(1,1-二甲基乙基)-1,3-噻唑-4-基) 吡啶-2-基] -2-氟苯基} -2,6-二氟苯磺酰胺或其药学上可接受的盐和N - {(1S)-2-氨基-1 - [(3,4-二氟苯基)甲基]乙基} -4-(4-氯-1-甲基-1H-吡唑-5-基)-2-呋喃甲酰胺或其药学上可接受的盐给有需要的人。

    Unified framework for precise vision-aided navigation
    50.
    发明授权
    Unified framework for precise vision-aided navigation 有权
    精准视觉辅助导航的统一框架

    公开(公告)号:US08174568B2

    公开(公告)日:2012-05-08

    申请号:US11949433

    申请日:2007-12-03

    Abstract: A system and method for efficiently locating in 3D an object of interest in a target scene using video information captured by a plurality of cameras. The system and method provide for multi-camera visual odometry wherein pose estimates are generated for each camera by all of the cameras in the multi-camera configuration. Furthermore, the system and method can locate and identify salient landmarks in the target scene using any of the cameras in the multi-camera configuration and compare the identified landmark against a database of previously identified landmarks. In addition, the system and method provide for the integration of video-based pose estimations with position measurement data captured by one or more secondary measurement sensors, such as, for example, Inertial Measurement Units (IMUs) and Global Positioning System (GPS) units.

    Abstract translation: 一种用于使用由多个摄像机捕获的视频信息有效地定位目标场景中的感兴趣对象的系统和方法。 该系统和方法提供多摄像机视觉测距,其中由多摄像机配置中的所有摄像机为每个摄像机生成姿态估计。 此外,系统和方法可以使用多摄像机配置中的任何摄像机来定位和识别目标场景中的突出地标,并将识别的地标与先前识别的地标的数据库进行比较。 另外,该系统和方法提供了基于视频的姿势估计与由一个或多个二次测量传感器捕获的位置测量数据的集成,例如惯性测量单元(IMU)和全球定位系统(GPS)单元 。

Patent Agency Ranking